Neptune Medical develops advanced medical devices with a primary focus on gastrointestinal robotics. The company’s mission is to enhance patient outcomes through innovative technology and collaborative partnerships. Neptune recently completed a $97M Series D financing, which the company says will strengthen its focus on GI robotics and expansion into robotics for GI disease. Neptune appointed medical robotics pioneer Dr. Fred Moll as Chairman of the Board, underscoring its emphasis on medical-robotics expertise. The company also spun out its subsidiary, Jupiter Endovascular, enabling that business to concentrate on a novel endovascular technology platform. Jupiter Endovascular is developing a new class of endovascular procedures to bring the precision and control of direct surgical access to catheter-based interventions.

Total raised

$97M

Funding rounds

1

Latest round

Series D

Latest activity

Aug 2024